Clinical Trial Update: Safety Study of BMS-844421 for Treatment of Hypercholesterolemia [Phase 1]

View source ↗

Summary

The document reports the termination of a Phase 1 safety trial evaluating BMS-844421 for hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypercholesterolemia

Drugs mentioned

• BMS-844421

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atherosclerosis, Hypercholesterolemia | Phase 1 | Status: TERMINATED